Phase One Results
Jeff Galvin discusses the Phase One results of gene and cell therapy, emphasizing the importance of safety and efficacy in treating patients with HIV. The study showed zero serious adverse events and blood markers of efficacy, indicating promising results for future treatments.In this clip
From this podcast
The Limited Partner
Jeff Galvin, CEO of Addimmune on Finding a Cure for HIV
Related Questions